These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 23493734)

  • 1. Lipid profile, lipid-lowering medications, and intracerebral hemorrhage after tPA in get with the guidelines-stroke.
    Messé SR; Pervez MA; Smith EE; Siddique KA; Hellkamp AS; Saver JL; Bhatt DL; Fonarow GC; Peterson ED; Schwamm LH
    Stroke; 2013 May; 44(5):1354-9. PubMed ID: 23493734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of in-hospital mortality and the risk of symptomatic intracerebral hemorrhage after thrombolytic therapy with recombinant tissue plasminogen activator in acute ischemic stroke.
    Al-Khaled M; Matthis C; Eggers J
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):7-11. PubMed ID: 22578915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe renal impairment is associated with symptomatic intracerebral hemorrhage after thrombolysis for ischemic stroke.
    Tütüncü S; Ziegler AM; Scheitz JF; Slowinski T; Rocco A; Endres M; Nolte CH
    Stroke; 2013 Nov; 44(11):3217-9. PubMed ID: 24003042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Race/Ethnic differences in the risk of hemorrhagic complications among patients with ischemic stroke receiving thrombolytic therapy.
    Mehta RH; Cox M; Smith EE; Xian Y; Bhatt DL; Fonarow GC; Peterson ED;
    Stroke; 2014 Aug; 45(8):2263-9. PubMed ID: 25070958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukoaraiosis, Cerebral Hemorrhage, and Outcome After Intravenous Thrombolysis for Acute Ischemic Stroke: A Meta-Analysis (v1).
    Charidimou A; Pasi M; Fiorelli M; Shams S; von Kummer R; Pantoni L; Rost N
    Stroke; 2016 Sep; 47(9):2364-72. PubMed ID: 27491738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptomatic intracerebral hemorrhage after intravenous thrombolysis in Chinese patients: comparison of prediction models.
    Li M; Wang-Qin RQ; Wang YL; Liu LB; Pan YS; Liao XL; Wang YJ; Xu AD
    J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1235-43. PubMed ID: 25891755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen decrease after intravenous thrombolysis in ischemic stroke patients is a risk factor for intracerebral hemorrhage.
    Vandelli L; Marietta M; Gambini M; Cavazzuti M; Trenti T; Cenci MA; Casoni F; Bigliardi G; Pentore R; Nichelli P; Zini A
    J Stroke Cerebrovasc Dis; 2015 Feb; 24(2):394-400. PubMed ID: 25497721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved prediction of poor outcome after thrombolysis using conservative definitions of symptomatic hemorrhage.
    Gumbinger C; Gruschka P; Böttinger M; Heerlein K; Barrows R; Hacke W; Ringleb P
    Stroke; 2012 Jan; 43(1):240-2. PubMed ID: 21998049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid profile, statin use, and outcome after intravenous thrombolysis for acute ischaemic stroke.
    Uyttenboogaart M; Koch MW; Koopman K; Vroomen PC; Luijckx GJ; De Keyser J
    J Neurol; 2008 Jun; 255(6):875-80. PubMed ID: 18338194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: a review of the risk factors.
    Lansberg MG; Albers GW; Wijman CA
    Cerebrovasc Dis; 2007; 24(1):1-10. PubMed ID: 17519538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
    Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA;
    Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk score for intracranial hemorrhage in patients with acute ischemic stroke treated with intravenous tissue-type plasminogen activator.
    Menon BK; Saver JL; Prabhakaran S; Reeves M; Liang L; Olson DM; Peterson ED; Hernandez AF; Fonarow GC; Schwamm LH; Smith EE
    Stroke; 2012 Sep; 43(9):2293-9. PubMed ID: 22811458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
    Hermann A; Dzialowski I; Koch R; Gahn G
    J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptomatic Intracerebral Hemorrhage after Intravenous Thrombolysis: Predictive Factors and Validation of Prediction Models.
    Nisar T; Hanumanthu R; Khandelwal P
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104360. PubMed ID: 31501036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.
    Seet RC; Rabinstein AA
    Cerebrovasc Dis; 2012; 34(2):106-14. PubMed ID: 22868870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Admission fibrinolytic profile is associated with symptomatic hemorrhagic transformation in stroke patients treated with tissue plasminogen activator.
    Ribo M; Montaner J; Molina CA; Arenillas JF; Santamarina E; Quintana M; Alvarez-Sabín J
    Stroke; 2004 Sep; 35(9):2123-7. PubMed ID: 15243150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of statin use and lipid profile on symptomatic intracerebral haemorrhage, outcome and mortality after intravenous thrombolysis in acute stroke.
    Rocco A; Sykora M; Ringleb P; Diedler J
    Cerebrovasc Dis; 2012; 33(4):362-8. PubMed ID: 22433177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and predictors of symptomatic intracerebral hemorrhage in patients with ischemic stroke treated with recombinant tissue plasminogen activator outside clinical trials.
    Martí-Fàbregas J; Bravo Y; Cocho D; Martí-Vilalta JL; Díaz-Manera J; San Román L; Puig M; Blanco M; Castellanos M; Millán M; Roquer J; Obach V; Maestre J
    Cerebrovasc Dis; 2007; 23(2-3):85-90. PubMed ID: 17114877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous Tissue Plasminogen Activator for Wake-Up Stroke: A Propensity Score-Matched Analysis.
    Anaissie JE; Monlezun DJ; Siegler JE; Waring ED; Dowell LN; Samai AA; George AJ; Kimbrough T; Berthaud J; Martin-Schild S
    J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2603-2609. PubMed ID: 27476340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?
    Lee SH; Kim BJ; Han MK; Park TH; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim JT; Choi K; Kim DE; Ryu WS; Kim WJ; Shin DI; Yeo M; Lee J; Lee JS; Gorelick PB; Bae HJ
    Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.